
Averx Drugs Private Limited
Pharmaceutical company manufacturing and distributing various drugs and chemical products.
Pharmaceutical company manufacturing and distributing various drugs and chemical products.
Averx Drugs Private Limited (ADPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 26 August 2014 and has a history of Ten years and six months. Its registered office is in Visakhapatnam, Andhra Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 9.91 Cr.
The company currently has active open charges totaling ₹7.48 Cr.
Srinivas Ramineni, Vns Kurapati, Dhana Tirupathi, and One other member serve as directors at the Company.
Visakhapatnam, Andhra Pradesh, India
+91-XXXXXXXXXX
-
U24100AP2014PTC095163
095163
Private Limited Indian Non-Government Company
26 Aug 2014
30 Nov 2021
31 Mar 2021
Unlisted
Roc Vijayawada
Averx Drugs Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Medicine, Animal Medicines & Health Care, Anthelmintics, Pharma Ingredients & Raw Materials, Anti Infective API.
Name | Designation | Appointment Date | Status |
---|---|---|---|
Nagasekhar Ramineni ![]() | Managing Director | 27-Mar-2019 | Current |
Name | Designation | Appointment Date | Status |
---|---|---|---|
Srinivas Ramineni ![]() | Additional Director | 29-Jan-2024 | Current |
Vns Kurapati ![]() | Director | 26-Aug-2014 | Current |
Dhana Tirupathi ![]() | Director | 25-Apr-2015 | Current |
Averx Drugs Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 209.54% increase. The company also saw a substantial improvement in profitability, with a 69.93% increase in profit. The company's net worth Soared by an impressive increase of 67.39%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2021, Averx Drugs had a promoter holding of 96.01% and a public holding of 3.99%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Srinivas Ramineni is a mutual person
Srinivas Ramineni is a mutual person
₹7.48 Cr
₹0
Date | Lender | Amount | Status |
---|---|---|---|
05 Sep 2018 | Others | ₹2.13 Cr | Open |
31 Aug 2016 | Others | ₹5.35 Cr | Open |
Unlock and access historical data on people associated with Averx Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Averx Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Averx Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Srinivas Ramineni was appointed as a Additional Director was appointed as a Additional Director on 29 Jan 2024 & has been associated with this company since 1 year 1 month .
Averx Drugs Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records.
Averx Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Vijayawada.
Nagasekhar Ramineni was appointed as a Managing Director was appointed as a Managing Director on 27 Mar 2019 & has been associated with this company since 5 years 11 months .
A charge with Others amounted to Rs. 2.13 Cr with Charge ID 100202612 was registered on 05 Sep 2018.
A charge with Others amounted to Rs. 5.35 Cr with Charge ID 100047169 was registered on 31 Aug 2016.
Averx Drugs Private Limited was incorporated on 26 Aug 2014.
The authorized share capital of Averx Drugs Private Limited is ₹ 10.00 Cr and paid-up capital is ₹ 9.91 Cr.
Currently 4 directors are associated with Averx Drugs Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Averx Drugs Private Limited is Plot No 27A 32A And 27A31 Denotified Area Lalamkoduru Rambilli, Atchuthapuram India, Paravada, Andhra Pradesh, 531019.
The corporate identification number (CIN) of Averx Drugs Private Limited is U24100AP2014PTC095163 and the company number is 095163 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2021, the revenue trend for Averx Drugs Private Limited has risen by 209.54%.
The financial reports for the fiscal year 2021 indicates that The net worth of Averx Drugs Private Limited has experienced an upsurge of 67.39%.
As per the financial statements for fiscal Year 2021, The total open charges for Averx Drugs Private Limited amount to ₹ 7.48 Cr.
The most recent Balance Sheet for Averx Drugs Private Limited was filed with the ROC on 31 Mar 2021.
VT
UB
RN
AN